Translate

Thứ Ba, 15 tháng 3, 2016

OncoBreak: Genetic Cancer Clues; Carbs and Cancer; Fame at Death

News, features, and commentary about cancer-related news

           
An analysis of 2,500 DNA samples has reviewed an identical genetic mutation in chronic lymphocytic leukemia, lung cancer, and breast cancer, providing a clue to the cancers' origin and potential treatment. (Cancer Research)
While on the topic of mutations and clues, an analysis of genetic markers across 30,000 people revealed a higher-than-expected rate of mutations in normal tissue, leading to speculation that the abnormalities may reflect premalignant states. (American Journal of Human Genetics)
The search for safe but effective pain control, including cancer-related pain, has led to an extract of spider toxin, according to a preclinical study published online in the British Journal of Pharmacology.
The FDA expanded approval of ibrutinib (Imbruvica) to include first-line treatment of chronic lymphocytic leukemia, making it the first chemotherapy-free regimen for the condition. (PR Newswire)
An oncologist-blogger from Brazil offers a snippet of the drug-regulation environment in his country.
In recognition of National Colorectal Cancer Awareness Month, the American Cancer Society reminds readers of common signs and symptoms and reviews some of the more promising research projects.
How carbohydrate intake may influence a person's risk of developing lung cancer. For more details of the study, read MedPage Today's coverage.
Having previously banned sale of tobacco products in its retail stores, CVS has announced plans to spend $50 million on anti-smoking initiatives. (Fortune)
Sacramento Kings coach George Karl -- a survivor of both prostate and head and neck cancer -- told reporters he will miss a little practice time for a minor surgical procedure related to throat cancer. (Sporting News)
An 8-year-old Rhode Island boy who wished for fame before dying has died of the cancer that prompted his quest. (WTIC-Hartford)
                                                                       

    Không có nhận xét nào:

    Đăng nhận xét